Detalles de la búsqueda
1.
A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and controls for pre-existing seasonal human coronavirus antibody cross-reactivity
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20207050
2.
SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21256207
3.
Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responses
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21251518
4.
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21259544
5.
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-473880
6.
Durability of SARS-CoV-2-specific T cell responses at 12-months post-infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-455984
7.
Durability of antibody responses and frequency of clinical and subclinical SARS-CoV-2 infection six months after BNT162b2 COVID-19 vaccination in healthcare workers
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21265087
8.
Post-vaccination Omicron infections induce broader immunity across antigenic space than prototype mRNA COVID-19 booster vaccination or primary infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-498883
Resultados
1 -
8
de 8
1
Próxima >
>>